Paper40586994
RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology.
Sakata A and 13 others. Jpn J Radiol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology. Papers, record 40586994. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40586994
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Glioma | Major topic |
| Neuroimaging | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Response Evaluation Criteria in Solid Tumors | Major topic |
| Humans | |
| Brain |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ISHIZUE 2024 | Kyoto University | PubMed |
Source PubMed
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39105956 | Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study. | J Neurooncol | 2024 | https://conductscience.org/library/papers/39105956 | PubMed |
| 2 | 37894340 | Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894340 | PubMed |
| 3 | 38222046 | Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study. | Neurooncol Pract | 2024 | https://conductscience.org/library/papers/38222046 | PubMed |
| 4 | 38181810 | PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. | Lancet Oncol | 2024 | https://conductscience.org/library/papers/38181810 | PubMed |
| 5 | 39659831 | Deep learning-based postoperative glioblastoma segmentation and extent of resection evaluation: Development, external validation, and model comparison. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/39659831 | PubMed |
| 6 | 34286277 | Radiological assessment schedule for 1p/19q-codeleted gliomas during the surveillance period using parametric modeling. | Neurooncol Adv | 2021 | https://conductscience.org/library/papers/34286277 | PubMed |
| 7 | 39548049 | Advancing clinical MRI exams with artificial intelligence: Japan's contributions and future prospects. | Jpn J Radiol | 2025 | https://conductscience.org/library/papers/39548049 | PubMed |
| 8 | 26545842 | Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/26545842 | PubMed |
| 9 | 39542725 | Development and Evaluation of Automated Artificial Intelligence-Based Brain Tumor Response Assessment in Patients with Glioblastoma. | AJNR Am J Neuroradiol | 2025 | https://conductscience.org/library/papers/39542725 | PubMed |
| 10 | 36538117 | Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas. | Brain Tumor Pathol | 2023 | https://conductscience.org/library/papers/36538117 | PubMed |
| 11 | 39999966 | A Radiologist's Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part I-Essential Information on Preoperative and Immediate Postoperative Imaging. | Korean J Radiol | 2025 | https://conductscience.org/library/papers/39999966 | PubMed |
| 12 | 22433826 | Imaging biomarkers of brain tumour margin and tumour invasion. | Br J Radiol | 2011 | https://conductscience.org/library/papers/22433826 | PubMed |
| 13 | 26250565 | Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. | Neuro Oncol | 2015 | https://conductscience.org/library/papers/26250565 | PubMed |
| 14 | 39570018 | Decoding Glioblastoma Heterogeneity: Neuroimaging Meets Machine Learning. | Neurosurgery | 2025 | https://conductscience.org/library/papers/39570018 | PubMed |
| 15 | 38646145 | Molecular diversity in isocitrate dehydrogenase-wild-type glioblastoma. | Brain Commun | 2024 | https://conductscience.org/library/papers/38646145 | PubMed |
| 16 | 38152383 | Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration. | Front Radiol | 2023 | https://conductscience.org/library/papers/38152383 | PubMed |
| 17 | 39041936 | Monitoring Patients with Glioblastoma by Using a Large Language Model: Accurate Summarization of Radiology Reports with GPT-4. | Radiology | 2024 | https://conductscience.org/library/papers/39041936 | PubMed |
| 18 | 40015559 | A Radiologist's Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part II-Essential Information on Post-Treatment Imaging. | Korean J Radiol | 2025 | https://conductscience.org/library/papers/40015559 | PubMed |
| 19 | 36832282 | Timing of Early Postoperative MRI following Primary Glioblastoma Surgery-A Retrospective Study of Contrast Enhancements in 311 Patients. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36832282 | PubMed |
| 20 | 38808755 | Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors. | Neuro Oncol | 2024 | https://conductscience.org/library/papers/38808755 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881455 | Late enhancement and washout maps for distinguishing tumor progression from radiation necrosis in malignant brain tumors: an exploratory study. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42881455 | PubMed |
| 42835612 | Reirradiation of recurrent brain tumors: a review by the ESTRO CNS Focus Group. | Clin Transl Radiat Oncol | 2027 | https://conductscience.org/library/papers/42835612 | PubMed |
| 42368382 | Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42368382 | PubMed |
| 42217076 | Imaging diagnosis of cystic intraparenchymal brain neoplasms. | Jpn J Radiol | 2026 | https://conductscience.org/library/papers/42217076 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40586994
GET https://conductscience.org/api/papers/v1/40586994/references?page=2